Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs HiPath IHC Family
Applied Spectral Imaging received South Korean Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67 - April 18, 2015
Applied Spectral Imaging Receives FDA Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67
FDA Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67 - January 24, 2015
Applied Spectral Imaging and Biocare Medical Partner to Deliver Comprehensive Solutions for Immunohistochemistry
A partnership making R2R workflow (“Reagent to Report”) a reality by combining Biocare’s automated IHC instrumentation and reagents with ASI’s computer-aided imaging and analysis. - December 07, 2013
BioDot and Applied Spectral Imaging Cooperate to Deliver Automated Genetic Analysis Solution
Enabling end-to-end, automated workflow for FISH and Karyotyping, from slide production to sample analysis and result reporting - June 07, 2013
Applied Spectral Imaging and WaveSense to Cooperate in Molecular Pathology and Cytogenetic FISH
Delivering a state-of-the-art integrated computerized analysis instrument and cell enrichment solution - April 24, 2013
World's First FDA Cleared ALK Automated Gene Scanner for Lung Cancer Therapy-Selection Available from ASI
Targeting the Right Treatment for the Right Patient in ALK Therapy Selection for Non-Small-Cell Lung Cancer - February 16, 2013
ASI Launches Go-Path – Computerized Immunohistochemistry Cancer Analysis Aid
GenASIs Go-Path – Industry’s Most Advanced Computer Aided Membrane and Nuclear Immunohistochemistry Imaging and Analysis Platform - January 09, 2013
Applied Spectral Imaging Launches Version 7.2 of GenASIs – A New Era in Pathology and Cytogenetic Imaging
GenASIs 7.2 – The Market’s Most Comprehensive Computer Aided Cytogenetic and Pathology Imaging and Analysis Platform - December 20, 2012
Olympus Europa and Applied Spectral Imaging Expand Cooperation by Establishing Sales and Marketing Framework Agreement
European framework agreement outlining the terms for distribution by Olympus subsidiaries in Europe of the GenASIs automated imaging platforms for genetic and pathological analysis. - May 31, 2012
FDA Clears ASI’s GenASIs Advanced Imaging for HER-2/neu Analysis
ASI’s GenASIs automated scanning and image analysis system for detection and quantifying chromosome 17 and the HER-2/neu gene has been cleared by the United States Food and Drug Administration (FDA) for marketing in the US. - February 22, 2012
FDA Clears ASI’s GenASIs Advanced Imaging for UroVysion Analysis
GenASIs Scan & Analysis cleared for FISH Detection and Analysis of chromosomal abnormalities in urine specimens. - February 01, 2012
Applied Spectral Imaging Announces the Launch of the GenASIs Automated Imaging Platforms for Genetic and Pathology Analysis
The GenASIs advanced cytogenetic and pathology platforms are the foundation of ASI’s new offering. With its superior imaging and analysis capabilities, ASI provides state of the art diagnostic aids, offering cytogeneticists and pathologists accurate genetic and pathology analysis. - December 24, 2011